Skip to main content
Signal8

Brughera Marco Maria

SEC insider (Form 3/4/5 filer). CIK 0001589776. Director at FENNEC PHARMACEUTICALS INC. (FENC). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in RESEARCH TRIANGLE PARK, NC.

Companies Brughera Marco Maria has filed insider reports for

  • FENNEC PHARMACEUTICALS INC. (FENC): Director
Brughera Marco Maria profile photo

Brughera Marco Maria

CIK: 0001589776

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (25.0%)

Position reduction

Option Exercises (M)1 (25.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

FENNEC PHARMACEUTICALS INC. logo
FENC

FENNEC PHARMACEUTICALS INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Sep 15, 2026
    Exercise
    Direct
    15.5K shares at avg. $2.11$33K
  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Sep 15, 2026
    Sale
    Direct
    15.5K shares at avg. $10.29$160K
  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Jun 10, 2026
    Award

    Stock Option

    Direct
    20K shares at avg. $8.70-
  • FENNEC PHARMACEUTICALS INC. logo
    FENC

    FENNEC PHARMACEUTICALS INC.

    Jun 3, 2025
    Award

    Stock Option

    Direct
    20K shares at avg. $7.88-

1-4 of 4